SCHEMBL6833459

SCHEMBL6833459

COc1ccc(-c2cnc(C(=O)Nc3ccc(C#N)cc3C(=O)O)o2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.48
HDAC6 Q9UBN7 5/20 0.46
HDAC1 Q13547 4/20 0.46
MAPT P10636 2/20 0.45
ALB P02768 2/20 0.45
THRB P10828 1/20 0.43
FAAH O00519 2/20 0.42
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42
TUBA1B P68363 1/20 0.42
TUBA4A P68366 1/20 0.42
TUBB4B P68371 1/20 0.42
TUBB3 Q13509 1/20 0.42
TUBB2A Q13885 1/20 0.42
TUBB8 Q3ZCM7 1/20 0.42
TUBA3E Q6PEY2 1/20 0.42
TUBA1A Q71U36 1/20 0.42
TUBA1C Q9BQE3 1/20 0.42
TUBB6 Q9BUF5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6834193 0.91 TUBB4A (0.47) RXFP1ALBFAAHTUBB4ATUBB
SCHEMBL6835728 0.90 HDAC1 (0.49) RXFP1HDAC6HDAC1MAPTALB
SCHEMBL6834034 0.88 TUBB4A (0.55) HDAC6HDAC1ALBFAAHTUBB4A
SCHEMBL6830630 0.87 TUBB4A (0.44) HDAC6HDAC1MAPTALBFAAH
SCHEMBL6833263 0.85 HDAC6 (0.51) HDAC6HDAC1MAPTFAAHTUBB4A
SCHEMBL6833423 0.84 FAAH (0.52) ALBFAAHTUBB4ATUBBTUBA3C
SCHEMBL6834004 0.83 TUBB4A (0.44) HDAC6HDAC1MAPTALBFAAH
SCHEMBL6833246 0.83 HDAC1 (0.47) RXFP1HDAC6HDAC1MAPTALB
SCHEMBL6818740 0.82 RXFP1 (0.71) RXFP1MAPTTHRBALDH1A1HPGD
SCHEMBL6834460 0.81 POLB (0.44) RXFP1MAPTALBTHRBFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 RXFP1 3523/4885HDAC6 963/4885HDAC1 1902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.